2025
SJR Q1
JCR Q1 · 6,5
OA
1 matched articles
SCIE
Journal detail
Visual Neuroscience
- Publisher
- Maximum Academic Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0952523814698714
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,116
- Quartile Q1
- H-Index 92
- Cites/doc 4,83
- Docs (3y) 19
- Cites (3y) 74
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 6,5
- 5Y JIF 3,5
- JCI 1,22
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Physiology Q2
- Sensory Systems Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Neuroscience
WoS categories
- Neurosciences | Ophthalmology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,116 | 6,5 | 3,5 | 1,22 | Q1 | 92 |
| 2024 | Q3 | Q2 | 0,515 | 2,3 | 2,1 | 0,55 | Q3 | 90 |
| 2023 | Q3 | Q3 | 0,472 | 1,1 | 2,2 | 0,32 | Q4 | 90 |
| 2022 | Q3 | Q3 | 0,453 | 1,9 | 2,7 | 0,47 | Q3 | 90 |
| 2021 | Q2 | Q4 | 0,791 | 1,9 | 3,1 | 0,74 | Q2 | 90 |
| 2020 | Q1 | Q2 | 1,957 | 3,2 | 2,9 | 0,85 | Q2 | 90 |
| 2019 | Q1 | Q1 | 1,357 | 3 | 2,3 | 0,76 | Q2 | 90 |
| 2018 | — | Q3 | — | 1,6 | 2,1 | 0,47 | Q3 | — |
| 2017 | Q2 | Q2 | 1,012 | 1,9 | 2,1 | 0,55 | Q3 | 90 |
| 2016 | Q1 | Q3 | 1,413 | 1,7 | 2 | — | — | 90 |
| 2015 | Q2 | Q2 | 1,153 | 1,9 | 1,9 | — | — | 90 |
| 2014 | Q2 | Q2 | 1,299 | 2,2 | 2,2 | — | — | 90 |
| 2013 | Q2 | Q3 | 1,349 | 1,7 | 1,7 | — | — | 90 |
| 2012 | Q2 | Q3 | 1,09 | 1,5 | 1,6 | — | — | 90 |
| 2011 | Q2 | Q2 | 1,139 | 2,2 | 1,7 | — | — | 90 |
| 2010 | Q2 | Q2 | 1,015 | 1,7 | 1,7 | — | — | 90 |
| 2009 | — | Q3 | — | 1,3 | 1,4 | — | — | — |
| 2008 | — | Q2 | — | 1,4 | 1,8 | — | — | — |
| 2007 | — | Q2 | — | 1,6 | 1,9 | — | — | — |
| 2006 | — | Q2 | — | 1,5 | — | — | — | — |
| 2005 | — | Q2 | — | 1,6 | — | — | — | — |
| 2004 | — | Q2 | — | 1,6 | — | — | — | — |
| 2003 | — | Q2 | — | 1,8 | — | — | — | — |
| 2002 | — | Q2 | — | 1,8 | — | — | — | — |
| 2001 | — | Q1 | — | 2,4 | — | — | — | — |
| 2000 | — | Q1 | — | 2,1 | — | — | — | — |
| 1999 | — | Q1 | — | 2,2 | — | — | — | — |
| 1998 | — | Q1 | — | 2,2 | — | — | — | — |
| 1997 | — | Q1 | — | 1,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | NEUROSCIENCES | SCIE | Q1 | Q1 | 45/330 |
| 2025 | OPHTHALMOLOGY | SCIE | Q1 | Q1 | 7/98 |
| 2024 | NEUROSCIENCES | SCIE | Q3 | Q4 | 213/314 |
| 2024 | OPHTHALMOLOGY | SCIE | Q2 | Q3 | 31/99 |
| 2023 | NEUROSCIENCES | SCIE | Q4 | Q4 | 283/310 |
| 2023 | OPHTHALMOLOGY | SCIE | Q3 | Q4 | 70/95 |
| 2022 | NEUROSCIENCES | SCIE | Q4 | Q4 | 235/272 |
| 2022 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 41/62 |
| 2021 | NEUROSCIENCES | SCIE | Q4 | Q3 | 246/275 |
| 2021 | OPHTHALMOLOGY | SCIE | Q4 | Q2 | 49/62 |
| 2020 | NEUROSCIENCES | SCIE | Q3 | Q2 | 171/273 |
| 2020 | OPHTHALMOLOGY | SCIE | Q2 | Q2 | 22/62 |
| 2019 | NEUROSCIENCES | SCIE | Q3 | Q3 | 140/272 |
| 2019 | OPHTHALMOLOGY | SCIE | Q1 | Q2 | 13/60 |
| 2018 | NEUROSCIENCES | SCIE | Q4 | Q4 | 228/267 |
| 2018 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 38/60 |
| 2017 | NEUROSCIENCES | SCIE | Q4 | Q3 | 204/261 |
| 2017 | OPHTHALMOLOGY | SCIE | Q2 | Q3 | 29/59 |
| 2016 | NEUROSCIENCES | SCIE | Q4 | — | 207/259 |
| 2016 | OPHTHALMOLOGY | SCIE | Q3 | — | 33/59 |
| 2015 | NEUROSCIENCES | SCIE | Q3 | — | 183/256 |
| 2015 | OPHTHALMOLOGY | SCIE | Q2 | — | 25/56 |
| 2014 | NEUROSCIENCES | SCIE | Q3 | — | 166/252 |
| 2014 | OPHTHALMOLOGY | SCIE | Q2 | — | 18/57 |
| 2013 | NEUROSCIENCES | SCIE | Q4 | — | 195/252 |
| 2013 | OPHTHALMOLOGY | SCIE | Q3 | — | 31/58 |
| 2012 | NEUROSCIENCES | SCIE | Q4 | — | 199/252 |
| 2012 | OPHTHALMOLOGY | SCIE | Q3 | — | 31/59 |
| 2011 | NEUROSCIENCES | SCIE | Q3 | — | 159/244 |
| 2011 | OPHTHALMOLOGY | SCIE | Q2 | — | 17/58 |
| 2010 | NEUROSCIENCES | SCIE | Q4 | — | 180/239 |
| 2010 | OPHTHALMOLOGY | SCIE | Q2 | — | 23/56 |
| 2009 | NEUROSCIENCES | SCIE | Q4 | — | 193/231 |
| 2009 | OPHTHALMOLOGY | SCIE | Q3 | — | 31/49 |
| 2008 | NEUROSCIENCES | SCIE | Q4 | — | 176/221 |
| 2008 | OPHTHALMOLOGY | SCIE | Q2 | — | 24/48 |
| 2007 | NEUROSCIENCES | SCIE | Q3 | — | 149/211 |
| 2007 | OPHTHALMOLOGY | SCIE | Q2 | — | 20/45 |
| 2006 | NEUROSCIENCES | SCIE | Q3 | — | 150/200 |
| 2006 | OPHTHALMOLOGY | SCIE | Q2 | — | 20/45 |
| 2005 | NEUROSCIENCES | SCIE | Q3 | — | 144/200 |
| 2005 | OPHTHALMOLOGY | SCIE | Q2 | — | 17/44 |
| 2004 | NEUROSCIENCES | SCIE | Q3 | — | 135/198 |
| 2004 | OPHTHALMOLOGY | SCIE | Q2 | — | 14/42 |
| 2003 | NEUROSCIENCES | SCIE | Q3 | — | 117/198 |
| 2003 | OPHTHALMOLOGY | SCIE | Q2 | — | 13/41 |
| 2002 | NEUROSCIENCES | SCIE | Q3 | — | 110/197 |
| 2002 | OPHTHALMOLOGY | SCIE | Q2 | — | 13/41 |
| 2001 | NEUROSCIENCES | SCIE | Q2 | — | 77/198 |
| 2001 | OPHTHALMOLOGY | SCIE | Q1 | — | 7/43 |
| 2000 | NEUROSCIENCES | SCIE | Q2 | — | 81/203 |
| 2000 | OPHTHALMOLOGY | SCIE | Q1 | — | 6/41 |
| 1999 | NEUROSCIENCES | SCIE | Q2 | — | 75/201 |
| 1999 | OPHTHALMOLOGY | SCIE | Q1 | — | 6/43 |
| 1998 | NEUROSCIENCES | SCIE | Q2 | — | 69/202 |
| 1998 | OPHTHALMOLOGY | SCIE | Q1 | — | 4/42 |
| 1997 | NEUROSCIENCES | SCIE | Q2 | — | 75/150 |
| 1997 | OPHTHALMOLOGY | SCIE | Q1 | — | 7/39 |